β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.
β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.
复制标题
DOI:
10.1371/journal.pone.0052911
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Liu H
中科院分区:
文献类型:
--
作者:
Du Y;Yan L;Wang J;Zhan W;Song K;Han X;Li X;Cao J;Liu H
Autoantibodies against the second extracellular loop of the β1-adrenergic receptor (β1-AA) not only contribute to increased susceptibility to heart failure, but also play a causative role in myocardial remodeling through their sympathomimetic-like effects that are induced upon binding to the β1-adrenergic receptor. However, their role in the function of T lymphocytes has never been previously investigated. Our present study was designed to determine whether β1-AA isolated from the sera of dilated cardiomyopathy (DCM) patients caused the proliferation of T cells and the secretion of cytokines. Blood samples were collected from 95 DCM patients as well as 95 healthy subjects, and β1-AA was detected using ELISA. The CD3+T lymphocytes were selected separately through flow cytometry and the effect of β1-AA on T lymphocyte proliferation was examined by CCK-8 kits and CFSE assay. Western blotting was used to analyze the expressions of phospho-VASP and phospho-p38 MAPK. β1-AA enhanced the proliferation of T lymphocytes. This effect could be blocked by the selective β1-adrenergic receptor antagonist metoprolol, PKA inhibitor H89, and p38 MAPK inhibitor SB203580. Furthermore, the expression of the phosphorylated forms of phospho-VASP and phospho-p38 MAPK were markedly increased in the presence of β1-AA. β1-AA also inhibited the secretion of interferon-γ (IFN-γ) while promoting an increase in interleukin-4 (IL-4) levels. These results demonstrate that β1-AA isolated from DCM patients binds to β1-AR on the surface of T cells, causing changes in T-cell proliferation and secretion through the β1-AR/cAMP/PKA and p38 MAPK pathways.
登录
查看更多内容
影响因子:
4.4
作者:
Ganapathy, V;Gurlo, T;von Grafenstein, H
通讯作者:
von Grafenstein, H
影响因子:
3.5
作者:
Magnusson, Y;Hjalmarson, A;Hoebeke, J
通讯作者:
Hoebeke, J
影响因子:
37.8
作者:
Jahns, R;Boivin, V;Boege, F
通讯作者:
Boege, F
影响因子:
5.4
作者:
Kitajima, Masayuki;Lee, Hai-Chon;Nakayama, Toshinori;Ziegler, Steven F.
通讯作者:
Ziegler, Steven F.
影响因子:
15.9
作者:
Jahns, R;Boivin, V;Lohse, MJ
通讯作者:
Lohse, MJ